Sort
34,240 grants matching “atherosclerosis”
Oxidation Resistant ApoA1 Gene Delivery Stents
$853,842Robert J Levy · Children'S Hosp Of Philadelphia · R01 · FY2017 · HL
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
$853,792Nicholas James Leeper · Stanford University · R35 · FY2022 · HL
The Genetic Determinants of Innate Immunity and Host Defense
$853,564David Schwartz · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
$853,512Nicholas James Leeper · Stanford University · R35 · FY2021 · HL
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
$853,390Nicholas James Leeper · Stanford University · R35 · FY2020 · HL
COMMON VARIANTS IN CANDIDATE GENES AND PREMATURE MI RISK
$853,124University Of Washington · R01 · FY2000 · HL
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes
$853,124Chad Albert Cowan · Massachusetts General Hospital · U01 · FY2011 · HL
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
$853,089R Graham Barr · Columbia University Health Sciences · R01 · FY2014 · HL
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
$853,060Nicholas James Leeper · Stanford University · R35 · FY2019 · HL
Sex and stress hormones control adrenal gland macrophage development and function"
$852,525Jesse Warren Williams · University Of Minnesota · R01 · FY2025 · AI
Cardiovascular Structure and Function in the Mucopolysaccharidoses
$852,280Raymond Yu Jeang Wang · Children'S Hospital Of Orange County · R01 · FY2025 · HL
Optimizing Cardiovascular Risk Prediction in HIV
$852,205Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2020 · HL
Regulation of Aldosterone: The Effect of Statins
$852,185Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2017 · HL
MESA
$852,175Joao A C Lima · Johns Hopkins University · N01 · FY2011 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$851,909Steven E Kahn · Seattle Inst For Biomedical/Clinical Res · U01 · FY2009 · DK
Lifestyle effects on hematopoiesis and atherosclerosis
$851,857Filip K Swirski · Massachusetts General Hospital · R01 · FY2017 · HL
Lifestyle effects on hematopoiesis and atherosclerosis
$851,857Filip K Swirski · Massachusetts General Hospital · R01 · FY2016 · HL
Lifestyle effects on hematopoiesis and atherosclerosis
$851,857Filip K Swirski · Massachusetts General Hospital · R01 · FY2018 · HL
Metabolic pathways of increased cardiovascular risk in type 2 diabetes
$851,576Alessandro Doria · Joslin Diabetes Center · R01 · FY2016 · HL
TRAF6 Nanoimmunotherapy to resolve plaque inflammation
$851,576Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5
$851,537Lynne E Wagenknecht · Wake Forest University Health Sciences · U01 · FY2017 · HL
Optimizing Cardiovascular Risk Prediction in HIV
$851,435Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2019 · HL
Clonal Hematopoiesis in Healthy Individuals from Families with Early OnsetCoronary Artery Disease
$851,405Lewis C Becker · Johns Hopkins University · R01 · FY2019 · HL
Psychosocial stress' effects on macrophage dynamics in atherosclerosis
$851,250Filip K Swirski · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · HL
Psychosocial stress' effects on macrophage dynamics in atherosclerosis
$851,250Filip K Swirski · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · HL